Back to Search
Start Over
Understanding the mechanisms mediating cardio-renal benefit of empagliflozin in type 2 diabetes mellitus.
- Source :
-
Journal of diabetes and its complications [J Diabetes Complications] 2023 Dec; Vol. 37 (12), pp. 108630. Date of Electronic Publication: 2023 Oct 23. - Publication Year :
- 2023
-
Abstract
- Competing Interests: Declaration of competing interest None.
- Subjects :
- Humans
Diabetic Nephropathies drug therapy
Cardiovascular Diseases prevention & control
Kidney drug effects
Kidney physiopathology
Diabetic Cardiomyopathies prevention & control
Glucosides therapeutic use
Glucosides pharmacology
Benzhydryl Compounds therapeutic use
Diabetes Mellitus, Type 2 drug therapy
Diabetes Mellitus, Type 2 complications
Sodium-Glucose Transporter 2 Inhibitors therapeutic use
Hypoglycemic Agents therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1873-460X
- Volume :
- 37
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Journal of diabetes and its complications
- Publication Type :
- Academic Journal
- Accession number :
- 39034649
- Full Text :
- https://doi.org/10.1016/j.jdiacomp.2023.108630